Target
Complement factor D
Ligand
BDBM352007
Substrate
n/a
Meas. Tech.
Inhibition Assay
IC50
<1000±n/a nM
Citation
 Wiles, JAPhadke, ASDeshpande, MAgarwal, AChen, DGadhachanda, VRHashimoto, APais, GWang, QWang, X Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders US Patent  US10822352 Publication Date 11/3/2020 
Target
Name:
Complement factor D
Synonyms:
Adipsin | C3 convertase activator | CFAD_HUMAN | CFD | DF | PFD | Properdin factor D
Type:
Protein
Mol. Mass.:
27039.19
Organism:
Homo sapiens (Human)
Description:
P00746
Residue:
253
Sequence:
MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA
  
Inhibitor
Name:
BDBM352007
Synonyms:
(2S,4R)-1-(2-(3-acetyl- 5-(2-(pyrrolidin-1- yl)pyrimidin-5-yl)-1H- indol-1-yl)acetyl)-N- (2'-chloro-2- fluorobiphenyl-3-yl)-4- fluoropyrrolidine-2- carboxamide | US10822352, Comp No. 26 | US9796741, cmp No. 26
Type:
Small organic molecule
Emp. Form.:
C37H33ClF2N6O3
Mol. Mass.:
683.146
SMILES:
CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2C(=O)Nc2cccc(c2F)-c2ccccc2Cl)c2ccc(cc12)-c1cnc(nc1)N1CCCC1 |r|
Structure:
Search PDB for entries with ligand similarity: